Please login to the form below

Diapharm Ltd.

Diapharm is an international full-service provider for the healthcare industry. We have been a partner for multinationals, SMEs and start-ups for more than 20 years.

This is a FREE listing




Below are full profiles from other companies in this area

Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market for the benefit of society. We provide commercial strategy services focused on product and portfolio planning, and pricing and market access strategies.

View profile

McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives.

View profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View profile

Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and flawless execution. We are an uncommon health communications agency with a deep understanding of today’s complex healthcare environment.

View profile

Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and its complexities, Onyx Health helps clients grow their brands and build their reputation to increase their sales.

View profile

OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market access.

View profile

Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with a focus on solutions that can have a significant and measurable impact on both healthcare professionals and patients’ lives.

View profile

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

View profile

Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking for comprehensive behavioural insights, a nudge in the right direction, or a complete creative campaign, we will deliver what you need to change behaviour for good.

View profile

Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy.

View profile

Company Details

Diapharm Ltd.

Telephone:+44 (0)203 1782790

Contact

Address:
20 Hanover Square
London
W1S 1JY
United Kingdom

Latest content from PMHub

Celebrating the hard work and dedication of our wonderful Talent Manager
Porterhouse Medical Group
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting too many patients to sign up could actually hinder the process.
COUCH Health
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid decentralised trials was slow. But when it became clear that existing and upcoming clinical trials wouldn’t be able to run as planned, biotech and pharma companies have been scrambling to work out how they can take their trial out of the clinic and into a virtual setting.
COUCH Health
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint in this week's instalment of our Pharma and COVID-19 series by Rare Immunology Global Medical Lead Karen Cheng
Frontera Group